María Ángeles Castilla

Author

Also Known As

M A Castilla, M Angeles Castilla, M Ángeles Castilla, M. Angeles Castilla, M. Ángeles Castilla, M. ángeles Castilla, M.A. Castilla, M.Ángeles Castilla, Maria A. Castilla, Maria Angeles Castilla

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Universidad Autónoma de Madrid Instituto de Biomedicina de Sevilla Universidad de Sevilla Hospital Universitario Ramón y Cajal

MÁ

About

María Ángeles Castilla is an author at Hospital Universitario Virgen del Rocío specializing in medicine, cell biology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	797
2	Cell Biology	10	10	578
3	Health Sciences	6	6	284
4	Immunology	6	6	385
5	Cellular Physiology	3	3	121

María Ángeles Castilla

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma María Ángeles Castilla, Gema Moreno‐Bueno, Laura Romero‐Pérez, The Journal of Pathology	2010	226
Lysyl oxidase‐like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal‐like breast carcinomas Gema Moreno‐Bueno, Fernando Salvador, Alberto Martín, EMBO Molecular Medicine	2011	153
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer Marta Hergueta‐Redondo, David Sarrió, Ángela Molina-Crespo, Oncotarget	2016	116
Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H<sub>2</sub>O<sub>2</sub> Francisco R. González‐Pacheco, Juan J. P. Deudero, María C. Castellanos, American Journal of Physiology-Heart and Circulatory Physiology Endothelial CellsImmunologyReactive Oxygen SpeciesRedox BiologyOxidative Stress	2006	105
MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes María Ángeles Castilla, Juan Díaz‐Martín, David Sarrió, PLoS ONE Breast OncologySpontaneous EmtPathologyCancer BiologyTumor Biology	2012	100
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Juan Díaz‐Martín, María Ángeles López‐García, Laura Romero‐Pérez, Endocrine Related Cancer	2015	87
ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma Laura Romero‐Pérez, M. Ángeles López-García, Juan Díaz‐Martín, Modern Pathology Tumor BiologyMicrorna-200 DownregulationUndifferentiated Endometrial CarcinomaMedicineZeb1 Overexpression	2013	76
Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. M V Alvarez Arroyo, María Ángeles Castilla, Francisco Román González Pacheco, Journal of the American Society of Nephrology InflammationAngiogenesisDevelopmental BiologyVascular AdaptationBaec Pretreatment	1998	75
A core <scp>microRNA</scp> signature associated with inducers of the epithelial‐to‐mesenchymal transition Juan Díaz‐Martín, Antonio Díaz‐López, Gema Moreno‐Bueno, The Journal of Pathology	2013	70
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer María Ángeles Castilla, María Ángeles López‐García, M. Atienza, Endocrine Related Cancer	2014	62

Page 1